Peripheral Arterial Disease Trial, Recruiting NCT06206369 Sponsor: Amsterdam UMC, location VUmc Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06206369
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women between 40 and 90 years old who have an abdominal aortic aneurysm (a bulge in the main blood vessel in the abdomen) larger than 3cm, in various locations in the abdomen or pelvis
  • Men and women between 40 and 90 years old who have an infection-related aneurysm (sometimes called a mycotic aneurysm) (confirm with trial site)
  • Men and women between 40 and 90 years old who have already had a procedure or a ruptured aneurysm in the past
  • Men and women between 40 and 90 years old who have peripheral artery disease (PAD), which is a condition where narrowed arteries reduce blood flow to the limbs, at any stage of severity

Who may not be able to join:

  • People who have an aneurysm in the upper chest area (ascending or thoracic aorta) or one that spans both the chest and abdomen (certain types of thoracoabdominal aneurysm) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 6 14278725

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Amsterdam UMC, location VUmc
Registry
ClinicalTrials.gov
Start date
31 October 2023
Est. completion
1 May 2029

Where this trial is recruiting

🇫🇮 Finland 🇩🇪 Germany 🇳🇱 Netherlands 🇵🇹 Portugal 🇷🇸 Serbia 🇬🇧 United Kingdom

Primary endpoints

Development of disease progression prediction algorithms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov